Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MYRIAD GENETICS INC Financial Overview

  • Income Statement: MYGN
      2009 2008 Change ( 2008 - 2009  )
    Net Sales/Revenues 326.53 M 222.86 M 103.67 M 31.75%
    Gross Profit 283.26 M 190.52 M 92.74 M 32.74%
    Net Income Before Extra Items/Preferred Div 84.62 M 47.84 M 36.77 M 43.46%
    Operating Income 126.46 M 61.60 M 64.86 M 51.29%
    View Full Report

  • Cash Flow: MYGN
      2009 2008 Change ( 2008 - 2009  )
    Net Cash Flow - Financing -51.92 M 21.87 M -73.80 M 142.12%
    Net Cash Flow - Investing 206.34 M 31.30 M 175.04 M 84.83%
    Net Cash Flow/Operating Activities 84.04 M 103.74 M -19.69 M -23.43%
    View Full Report

  • Balance Sheet: MYGN

      2009 2008 Change ( 2008 - 2009  )
    Total Assets 466.42 M 499.34 M -32.92 M -7.06%
    Total Liabilities 32.20 M 73.69 M -41.48 M -128.83%
    Shareholders Equity 434.22 M 425.66 M 8.56 M 1.97%
    View Full Report

  • Key Ratios / Statistics: MYGN

    • Valuation

      Price/Earnings (TTM) 32.48
      Price/Sales (TTM) 9.28
      Price/Book (MRQ) 5.57
      Price/Cash Flow (TTM) 15.84

    • Profitability

      Gross Margin 86.75
      Operating Margin 38.73
      Profit Margin 25.91

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 11.25
      Current Ratio (MRQ) 19.55
      Long Term Debt-to-Equity (MRQ) 0.00

    • Management Effectiveness

      Return on Equity (TTM) 21.48
      Return on Assets (TTM) 19.62
      Return on Investments (TTM) 19.68
    View All Key Ratios